H.R. 3016 · 116th Congress
Liver Illness Visibility, Education, and Research Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
VelázquezSponsor16 cosponsors · 15 D, 1 R
D
Espaillat
BF
R
Fitzpatrick
TG
D
Gabbard
BL
D
Lee
EN
D
Norton
FV
D
Vela
SJ
D
Jackson Lee
GM
D
Meeks
BT
D
Thompson
DM
D
Mucarsel-Powell
SC
D
Cohen
JH
D
Harder
TL
D
Lieu
CR
D
Ruppersberger
AD
D
Delgado
CL
D
Lamb6 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Liver Illness Visibility, Education, and Research Act of 2019 This bill expands and coordinates activities related to the research of liver cancer and liver disease, including causes, prevention, detection, and treatment.
What it does: CRS summary · Introduced in House · May 23, 2019
Liver Illness Visibility, Education, and Research Act of 2019
This bill expands and coordinates activities related to the research of liver cancer and liver disease, including causes, prevention, detection, and treatment. Specifically, the National Cancer Institute must establish an inter-institute working group to coordinate efforts to cure liver cancer and liver disease, including research into such cases resulting from hepatitis B, and may award grants to develop preventative and diagnostic measures as well as support for experimental treatment options.
The bill further establishes grant programs, administered by the Centers for Disease Control and Prevention, to support liver disease prevention services, diagnostics, and hepatitis tracking programs and to raise awareness about liver disease within high-risk communities.
The renamed National Institute of Diabetes and Digestive, Kidney, and Liver Diseases also must prioritize programs addressing liver disease, including (1) establishing a national clearinghouse for patient data and (2) developing or expanding the centers for research of liver disease.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Liver Illness Visibility, Education, and Research Act of 2019
Latest action (May 24, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 23, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.